Fusion Protein Inhibitors [MoA]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Fusion Protein Inhibitors [MoA] includes 2 drugs with a combined 11,666 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
11,666
Combined Reports
All Fusion Protein Inhibitors [MoA] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| PALIVIZUMAB | Synagis | 11,419 | 1,248 | 6,461 | 10.9% |
| NIRSEVIMAB | BEYFORTUS | 247 | 5 | 149 | 2.0% |
Common Side Effects in Fusion Protein Inhibitors [MoA] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Respiratory syncytial virus infection | 1,730 | 47 |
| Pyrexia | 1,070 | 25 |
| Death | 856 | 856 |
| Bronchiolitis | 738 | 14 |
| Cough | 684 | 9 |
| Pneumonia | 662 | 56 |
| Dyspnoea | 471 | 10 |
| Nasopharyngitis | 462 | 4 |
| Vomiting | 451 | 18 |
| Influenza | 398 | 7 |